There were 1,515 press releases posted in the last 24 hours and 405,877 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Bond Biosciences Announces Successful Pre-IND Meeting with the FDA to Advance the Development of BBI-001 for Treatment of Iron Overload Associated with Hereditary Hemochromatosis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.